Overview

Stem Cells for the Treatment of Pouchitis

Status:
Withdrawn

Trial end date:
2024-02-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the safety and feasibility of using allogeneic bone marrow derived mesenchymal stem cells (MSCs) to treat people with medically refractory Pouchitis.

Phase:

Phase 1

Details

Lead Sponsor:

The Cleveland Clinic

Collaborator:

Case Western Reserve University